Author

Noémi Csákány-Papp

THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PANCREATIC DUCTAL EPITHELIAL CELLS UNDER PATHOPHYSOLOGICAL CONDITIONS
THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PANCREATIC DUCTAL EPITHELIAL CELLS UNDER PATHOPHYSOLOGICAL CONDITIONS

Noémi Csákány-Papp  et al.

AZATHIOPRINE IMPAIRS PANCREATIC DUCTAL CHLORIDE AND BICARBONATE SECRETION BY DISRUPTING CFTR PLASMA MEMBRANE RETENTION IN MICE
AZATHIOPRINE IMPAIRS PANCREATIC DUCTAL CHLORIDE AND BICARBONATE SECRETION BY DISRUPTING CFTR PLASMA MEMBRANE RETENTION IN MICE

Noémi Csákány-Papp  et al.

LDN-071, A NOVEL FIRST-IN-CLASS PEPTIDE-BASED PLASMINOGEN ACTIVATOR INHIBITOR 1, SIGNIFICANTLY REDUCES THE SEVERITY OF EXPERIMENTAL COLITIS IN MICE
LDN-071, A NOVEL FIRST-IN-CLASS PEPTIDE-BASED PLASMINOGEN ACTIVATOR INHIBITOR 1, SIGNIFICANTLY REDUCES THE SEVERITY OF EXPERIMENTAL COLITIS IN MICE

Noémi Csákány-Papp  et al.

ORAI1 CALCIUM CHANNEL INHIBITION PREVENTS PROGRESSION OF RECURRENT ACUTE AND CHRONIC PANCREATITIS
ORAI1 CALCIUM CHANNEL INHIBITION PREVENTS PROGRESSION OF RECURRENT ACUTE AND CHRONIC PANCREATITIS

Noémi Csákány-Papp  et al.

INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS
INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS

Noémi Csákány-Papp  et al.

PLASMINOGEN ACTIVATOR INHIBITOR 1 A POTENTIAL NEW THERAPEUTIC TARGET IN THE TREATMENT OF CHRONIC PANCREATITIS
PLASMINOGEN ACTIVATOR INHIBITOR 1 A POTENTIAL NEW THERAPEUTIC TARGET IN THE TREATMENT OF CHRONIC PANCREATITIS

Noémi Csákány-Papp  et al.

Item 1 - 6 / 6
1